article thumbnail

Can liquid biopsies transform precision medicine?

Drug Discovery World

Brett Swansiger, Chief Commercial Officer at ANGLE discusses the importance of liquid biopsies in precision medicine trials for cancer. 23 Data analysed from the National Survey of Precision Medicine in Cancer Treatment reported that 75.6% 22 Ring et al., 22 Ring et al.,

article thumbnail

Predictive diagnostics: closing the precision medicine gap

Drug Discovery World

Precision medicine promises a paradigm shift to confidently match the right patients to the right treatment at the right time. Inherent to therapies developed during this era of precision medicine is the notion that many of these new therapies only work in a subset of patients.

article thumbnail

Can your LNP manufacturing platform cope with the pace of the mRNA revolution?

Pharmaceutical Technology

Genomic medicine development was ranked as the top industry trend for 2023 in a survey of 198 GlobalData Pharma clients and prospects conducted between October and November 2022. GlobalData pharmaceutical analysts project that RNA-based gene therapies for oncology will grow from zero in 2022 to $4.6 billion by 2028. billion by 2028.